rs1141528

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001023570.4(IQCB1):​c.1178T>A​(p.Ile393Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.117 in 1,613,104 control chromosomes in the GnomAD database, including 12,634 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.089 ( 813 hom., cov: 32)
Exomes 𝑓: 0.12 ( 11821 hom. )

Consequence

IQCB1
NM_001023570.4 missense

Scores

5
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10O:1

Conservation

PhyloP100: 1.34

Publications

37 publications found
Variant links:
Genes affected
IQCB1 (HGNC:28949): (IQ motif containing B1) This gene encodes a nephrocystin protein that interacts with calmodulin and the retinitis pigmentosa GTPase regulator protein. The encoded protein has a central coiled-coil region and two calmodulin-binding IQ domains. It is localized to the primary cilia of renal epithelial cells and connecting cilia of photoreceptor cells. The protein is thought to play a role in ciliary function. Defects in this gene result in Senior-Loken syndrome type 5. Alternative splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 6. [provided by RefSeq, Jan 2016]
IQCB1 Gene-Disease associations (from GenCC):
  • Senior-Loken syndrome 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Leber congenital amaurosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Senior-Loken syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002072066).
BP6
Variant 3-121788384-A-T is Benign according to our data. Variant chr3-121788384-A-T is described in ClinVar as Benign. ClinVar VariationId is 167196.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.13 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IQCB1NM_001023570.4 linkc.1178T>A p.Ile393Asn missense_variant Exon 12 of 15 ENST00000310864.11 NP_001018864.2 Q15051-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IQCB1ENST00000310864.11 linkc.1178T>A p.Ile393Asn missense_variant Exon 12 of 15 1 NM_001023570.4 ENSP00000311505.6 Q15051-1
IQCB1ENST00000349820.10 linkc.779T>A p.Ile260Asn missense_variant Exon 9 of 12 1 ENSP00000323756.7 Q15051-2
IQCB1ENST00000393650.7 linkn.*156T>A non_coding_transcript_exon_variant Exon 11 of 14 5 ENSP00000377261.3 Q15051-3
IQCB1ENST00000393650.7 linkn.*156T>A 3_prime_UTR_variant Exon 11 of 14 5 ENSP00000377261.3 Q15051-3

Frequencies

GnomAD3 genomes
AF:
0.0894
AC:
13593
AN:
152082
Hom.:
813
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0356
Gnomad AMI
AF:
0.247
Gnomad AMR
AF:
0.0633
Gnomad ASJ
AF:
0.0980
Gnomad EAS
AF:
0.00193
Gnomad SAS
AF:
0.0257
Gnomad FIN
AF:
0.119
Gnomad MID
AF:
0.0823
Gnomad NFE
AF:
0.132
Gnomad OTH
AF:
0.0925
GnomAD2 exomes
AF:
0.0914
AC:
22980
AN:
251436
AF XY:
0.0914
show subpopulations
Gnomad AFR exome
AF:
0.0350
Gnomad AMR exome
AF:
0.0561
Gnomad ASJ exome
AF:
0.0910
Gnomad EAS exome
AF:
0.00272
Gnomad FIN exome
AF:
0.117
Gnomad NFE exome
AF:
0.137
Gnomad OTH exome
AF:
0.0934
GnomAD4 exome
AF:
0.120
AC:
174882
AN:
1460904
Hom.:
11821
Cov.:
31
AF XY:
0.117
AC XY:
84776
AN XY:
726770
show subpopulations
African (AFR)
AF:
0.0295
AC:
987
AN:
33466
American (AMR)
AF:
0.0584
AC:
2610
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0854
AC:
2231
AN:
26126
East Asian (EAS)
AF:
0.00184
AC:
73
AN:
39674
South Asian (SAS)
AF:
0.0295
AC:
2547
AN:
86242
European-Finnish (FIN)
AF:
0.117
AC:
6266
AN:
53370
Middle Eastern (MID)
AF:
0.0553
AC:
319
AN:
5764
European-Non Finnish (NFE)
AF:
0.138
AC:
153698
AN:
1111180
Other (OTH)
AF:
0.102
AC:
6151
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
7520
15039
22559
30078
37598
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5374
10748
16122
21496
26870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0893
AC:
13591
AN:
152200
Hom.:
813
Cov.:
32
AF XY:
0.0856
AC XY:
6367
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.0354
AC:
1472
AN:
41556
American (AMR)
AF:
0.0631
AC:
966
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0980
AC:
340
AN:
3468
East Asian (EAS)
AF:
0.00193
AC:
10
AN:
5180
South Asian (SAS)
AF:
0.0261
AC:
126
AN:
4828
European-Finnish (FIN)
AF:
0.119
AC:
1254
AN:
10564
Middle Eastern (MID)
AF:
0.0850
AC:
25
AN:
294
European-Non Finnish (NFE)
AF:
0.132
AC:
8982
AN:
67994
Other (OTH)
AF:
0.0911
AC:
192
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
593
1186
1779
2372
2965
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
148
296
444
592
740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.118
Hom.:
349
Bravo
AF:
0.0868
TwinsUK
AF:
0.149
AC:
551
ALSPAC
AF:
0.134
AC:
515
ESP6500AA
AF:
0.0370
AC:
163
ESP6500EA
AF:
0.130
AC:
1118
ExAC
AF:
0.0931
AC:
11300
Asia WGS
AF:
0.0200
AC:
69
AN:
3478
EpiCase
AF:
0.128
EpiControl
AF:
0.131

ClinVar

Significance: Benign
Submissions summary: Benign:10Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 28, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Senior-Loken syndrome 5 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jan 18, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 22183348) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nephronophthisis Benign:1Other:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.091
T;.
Eigen
Benign
-0.042
Eigen_PC
Benign
0.020
FATHMM_MKL
Benign
0.72
D
LIST_S2
Uncertain
0.91
D;D
MetaRNN
Benign
0.0021
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.0
M;.
PhyloP100
1.3
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-1.3
N;N
REVEL
Benign
0.021
Sift
Benign
0.064
T;D
Sift4G
Uncertain
0.020
D;D
Polyphen
0.81
P;P
Vest4
0.26
MPC
0.46
ClinPred
0.022
T
GERP RS
2.2
Varity_R
0.29
gMVP
0.34
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1141528; hg19: chr3-121507231; COSMIC: COSV60438765; API